Videos

"The cemetery was the place where Jewish life was concentrated at the end. It was the place where people went to sunbathe, children had to play, ..." Literature scholar Annelies Augustyns (VUB - UAntwerp - FWO) studied German-Jewish diaries from WWII for her PhD. These offer a glimpse into the "everyday" life of Jews in the Third Reich.

Radiation can save the lives of people with head and neck cancer. Unfortunately, many patients develop swallowing disorders as a result of the treatment, which makes it impossible for them to eat solid food. Leen Van den Steen (UAntwerpen - UZA) wants to help them. How? With tongue strength training.

Biologist Sébastjen Schoenaers (UAntwerpen) watches his son Ferre grow rapidly. Yet Ferre grows 150 times slower than an ordinary corn leaf 🌱 We still don't understand how plants do this. Sébastjen zooms in on the plant up to molecular level to figure out how it really grows 🔬 This can help us grow plants better and faster.

Heart failure patients have a lot of trouble with physical exertion. They can barely even walk the dog. To improve their condition, they can follow training programs in the hospital. But more than half of the patients hardly benefit from them. Cardiologist in training Isabel Witvrouwen (UAntwerpen - University Hospital Antwerp) is trying to find out why.

All the elements we find here on earth were created long ago in the universe, floating around space in the form of stardust, coming from massive stars. "If we want to understand earth and where we came from, we need to understand these massive stars", says astronomer Abigail Frost (KU Leuven). That's why, using a technique called interferometry, she observes these rare and very distant stars.

5 million Flemings do not live in a city centre, but in villages or city outskirts. This fragmentation creates a major challenge: how do you connect all these houses to the sewerage network and how do you ensure smooth and sustainable mobility? Does everyone have to move to the city? No, as architect and urban designer Sophie Leemans (KU Leuven) explains in this video.

Family parties are a nightmare for those who wear hearing aids. With all those people talking at the same time, they find it difficult to hold a conversation. Engineer Simon Geirnaert is working on a solution. With his brain-controlled hearing aids, he also wants to help people with a hearing aid to communicate with each other.

Do you remember baby Pia? She suffered from the rare muscle disease AMS and the medicine to save her cost a whopping €1.9 million. If you were the Minister of Health, would you pay for Pia's medicine? Even if that meant there was no budget left for another medicine that might save 100 people?

Have you ever been stressed because you had to give a presentation? What if we told you that linguistic research could give you the key to becoming a better presenter in any language of the world? Linguist Charlotte Bourgoin (KU Leuven) studies the "information structure of speech" in different languages. Her research can help you better convey information and thus become a better presenter, both in your native language and in foreign languages.

During a stroke, every second counts to save as many brain cells as possible. Intervention is only possible within a narrow time window of a few hours because late treatment can lead to serious complications. Is there nothing more we can do for these 'late' patients? There is, says neurologist trainee Lauranne Scheldeman!

In 2008 banks took too many risks and lied about their true condition. Their collapse led to a worldwide financial crisis, that had a huge impact on society. You may think that everything is better now, but is it? Or do banks only look safer than they really are? That's what Elizaveta Sizova (KU Leuven) is investigating, in order to assess bank risk.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.